Orphanet (www.orpha.net) is a unique resource, gathering and improving knowledge on rare diseases so as to improve the diagnosis, care and treatment of patients with rare diseases.

To mark its 20th anniversary, the Orphanet website is undergoing a complete makeover, starting with the look and feel of the site.

 

E-Rare associates with Blackswan Foundation to co-organize 4th International Congress on Reaserch of Rare and Orphan Diseases - RE(ACT) 2018.

The congress will take place from 7-10 of March 2018 in Bologna, Italy.

 

European Medicines Agency has published the final guidance document for applicants to Horizon 2020 topic “New therapies for rare diseases” on the EMA website. Find more information HERE

EMA publishes guidelines for applicants to H2020 rare diseases calls

EMA publishes guidelines for applicants to H2020 rare diseases calls

European Medicines Agency has published the final guidance document for applicants to Horizon 2020 topic “New therapies for rare diseases” on the EMA website.

This document is specifically targeted to academic applicants to Horizon 2020 with the aim to outline some regulatory concepts and the time-frame of orphan designation and protocol assistance procedure.

You will find more information on: http://www.ema.europa.eu/ema/index.jsp?curl=pages/regulation/general/gen...

The link to download the PDF version of guidelines click HERE

E-Rare 2012 - Created by Toussaint Biger